|
|
| | Carfilzomib Impurity 35 Basic information |
| Product Name: | Carfilzomib Impurity 35 | | Synonyms: | Carfilzomib Impurity 35;Carbamic acid, N-[(1R)-3-methyl-1-[[(2R)-2-methyl-2-oxiranyl]carbonyl]butyl]-, 1,1-dimethylethyl ester;Caffezomib Impurity 65;(R)-t-Butyl 2-((4-methyl-1-(1-methylcyclopropyl)-1-oxopentan-2-yl)amino)acetate (>85%) | | CAS: | 2177287-68-0 | | MF: | C14H25NO4 | | MW: | 271.35 | | EINECS: | | | Product Categories: | | | Mol File: | 2177287-68-0.mol |  |
| | Carfilzomib Impurity 35 Chemical Properties |
| Boiling point | 369.8±37.0 °C(Predicted) | | density | 1.061±0.06 g/cm3(Predicted) | | pka | 11.08±0.46(Predicted) | | form | Solid | | color | White |
| | Carfilzomib Impurity 35 Usage And Synthesis |
| Uses | (R)-t-Butyl 2-((4-methyl-1-(1-methylcyclopropyl)-1-oxopentan-2-yl)amino)acetate is an intermediate in synthesizing (R)-2-Amino-4-methyl-1-((S)-2-methyloxiran-2-yl)pentan-1-one Trifluoroacetate Salt (A605100), an impurity of carfilzomib (C183460). Carfilzomib is a second-generation proteasome inhibitor that is used as a treatment in relapsed and refractory multiple myeloma. |
| | Carfilzomib Impurity 35 Preparation Products And Raw materials |
|